HPE Instant AOS-10 Command Line Interface path traversal
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.7 | $5k-$25k | 0.00 |
Summary
A vulnerability identified as critical has been detected in HPE Aruba Networking Access Point, Instant AOS-8 and Instant AOS-10. Affected is an unknown function of the component Command Line Interface. The manipulation leads to path traversal. This vulnerability is documented as CVE-2024-47464. The attack can be initiated remotely. There is not any exploit available.
Details
A vulnerability was found in HPE Aruba Networking Access Point, Instant AOS-8 and Instant AOS-10 (affected version not known) and classified as problematic. This issue affects some unknown functionality of the component Command Line Interface. The manipulation with an unknown input leads to a path traversal vulnerability. Using CWE to declare the problem leads to CWE-22. The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory. Impacted is confidentiality. The summary by CVE is:
An authenticated Path Traversal vulnerability exists in Instant AOS-8 and AOS-10. Successful exploitation of this vulnerability allows an attacker to copy arbitrary files to a user readable location from the command line interface of the underlying operating system, which could lead to a remote unauthorized access to files.
It is possible to read the advisory at support.hpe.com. The identification of this vulnerability is CVE-2024-47464 since 09/24/2024. The exploitation is known to be easy. The attack may be initiated remotely. The exploitation needs additional levels of successful authentication. The technical details are unknown and an exploit is not publicly available. The pricing for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 11/06/2024). The attack technique deployed by this issue is T1006 according to MITRE ATT&CK.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Be aware that VulDB is the high quality source for vulnerability data.
Product
Vendor
Name
License
Website
- Vendor: https://www.hpe.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.7VulDB Meta Temp Score: 4.7
VulDB Base Score: 2.7
VulDB Temp Score: 2.7
VulDB Vector: 🔍
VulDB Reliability: 🔍
CNA Base Score: 6.8
CNA Vector (hpe): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Path traversalCWE: CWE-22
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
09/24/2024 🔍11/06/2024 🔍
11/06/2024 🔍
11/06/2024 🔍
Sources
Vendor: hpe.comAdvisory: support.hpe.com
Status: Confirmed
CVE: CVE-2024-47464 (🔍)
GCVE (CVE): GCVE-0-2024-47464
GCVE (VulDB): GCVE-100-283271
Entry
Created: 11/06/2024 03:53Changes: 11/06/2024 03:53 (61)
Complete: 🔍
Cache ID: 216::103
Be aware that VulDB is the high quality source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.